How nescience may obscure evidence

@article{SautterBihl2014HowNM,
  title={How nescience may obscure evidence},
  author={Prof. Dr. med. M.-L. Sautter-Bihl and Felix Sedlmayer and Wilfried Budach and Juergen Dunst and Petra Christine Feyer and Rainer Fietkau and Wulf Haase and Wolfgang Harms and Marc Dieter Piroth and Rainer Souchon and Frederik Wenz and Rolf Sauer},
  journal={Strahlentherapie und Onkologie},
  year={2014},
  volume={190},
  pages={861-863}
}
limitations of the study were recognized and let to some critical comments [7], current guidelines [8, 14] rapidly adopted the omission of ALND in these selected patients. Unreckoned insights about the quality of evidence generated by the Z0011-trial were provided by a recent publication on behalf of the Alliance for Clinical Trials in Oncology by Jagsi et al. Briefly, the study [3] (published in 2011) comprised 891 women from 115 institutions with a clinically negative axilla who underwent… CONTINUE READING
4 Citations
14 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 14 references

Breast Cancer Expert Panel of the German Society of Radiation Oncology ( DEGRO ) . DEGRO practical guidelines : radiotherapy of breast cancer III – radiotherapy of the lymphatic pathways

  • PJ Schlembach, TA Buchholz, MI Ross
  • Strahlenther Onkol
  • 2014

Similar Papers

Loading similar papers…